These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18478182)

  • 1. Effect of the H2 receptor antagonist nizatidine on xerostomia in patients with primary Sjögren's syndrome.
    Kasama T; Shiozawa F; Isozaki T; Matsunawa M; Wakabayashi K; Odai T; Yajima N; Miwa Y; Negishi M; Ide H
    Mod Rheumatol; 2008; 18(5):455-9. PubMed ID: 18478182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sjogren's syndrome: promising, new treatment options besides nizatidine.
    Kapoor S
    Mod Rheumatol; 2009; 19(1):100-1. PubMed ID: 18841440
    [No Abstract]   [Full Text] [Related]  

  • 3. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
    Khurshudian AV
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nizatidine enhances salivary secretion in patients with dry mouth.
    Nin T; Umemoto M; Negoro A; Miuchi S; Sakagami M
    Auris Nasus Larynx; 2008 Jun; 35(2):224-9. PubMed ID: 18082986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome.
    Bowman SJ; Everett CC; O'Dwyer JL; Emery P; Pitzalis C; Ng WF; Pease CT; Price EJ; Sutcliffe N; Gendi NST; Hall FC; Ruddock SP; Fernandez C; Reynolds C; Hulme CT; Davies KA; Edwards CJ; Lanyon PC; Moots RJ; Roussou E; Giles IP; Sharples LD; Bombardieri M
    Arthritis Rheumatol; 2017 Jul; 69(7):1440-1450. PubMed ID: 28296257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the clinical efficacy of Biotène Oral Balance in patients with secondary Sjögren's syndrome: a pilot study.
    Aliko A; Alushi A; Tafaj A; Isufi R
    Rheumatol Int; 2012 Sep; 32(9):2877-81. PubMed ID: 21898068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
    Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P
    Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of orally administered pilocarpine hydrochloride for patients with juvenile-onset Sjögren's syndrome.
    Tomiita M; Takei S; Kuwada N; Nonaka Y; Saito K; Shimojo N; Kohno Y
    Mod Rheumatol; 2010 Oct; 20(5):486-90. PubMed ID: 20517630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study.
    Leung KC; McMillan AS; Wong MC; Leung WK; Mok MY; Lau CS
    Clin Rheumatol; 2008 Apr; 27(4):429-36. PubMed ID: 17899308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study.
    Mariette X; Seror R; Quartuccio L; Baron G; Salvin S; Fabris M; Desmoulins F; Nocturne G; Ravaud P; De Vita S
    Ann Rheum Dis; 2015 Mar; 74(3):526-31. PubMed ID: 24347569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of nizatidine and famotidine for maintenance therapy of erosive esophagitis.
    Hamamoto N; Hashimoto T; Adachi K; Hirakawa K; Ishihara S; Inoue H; Taniura H; Niigaki M; Sato S; Kushiyama Y; Suetsugu H; Miyake T; Kinoshita Y
    J Gastroenterol Hepatol; 2005 Feb; 20(2):281-6. PubMed ID: 15683433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of xerostomia in patients with primary Sjögren's syndrome with sulfarlem.
    Schiødt M; Oxholm P; Jacobsen A
    Scand J Rheumatol Suppl; 1986; 61():250-2. PubMed ID: 3473639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral manifestations in patients with Sjögren's syndrome.
    Soto-Rojas AE; Villa AR; Sifuentes-Osornio J; Alarcón-Segovia D; Kraus A
    J Rheumatol; 1998 May; 25(5):906-10. PubMed ID: 9598889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with pilocarpine hydrochloride for sicca symptoms in Sjögren's syndrome].
    Takaya M; Ichikawa Y; Yamada C; Hoshina Y; Horiki T; Uchiyama M
    Ryumachi; 1997 Jun; 37(3):453-7. PubMed ID: 9256028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome: a double-blind randomized controlled trial.
    Cifuentes M; Del Barrio-Díaz P; Vera-Kellet C
    Br J Dermatol; 2018 Nov; 179(5):1056-1061. PubMed ID: 29432648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Xerostom
    López-Pintor RM; Ramírez L; Serrano J; de Pedro M; Fernández-Castro M; Casañas E; Hernández G
    Oral Dis; 2019 Apr; 25(3):772-780. PubMed ID: 30561129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilocarpine hydrochloride for the treatment of xerostomia in patients with Sjögren's syndrome in Taiwan--a double-blind, placebo-controlled trial.
    Wu CH; Hsieh SC; Lee KL; Li KJ; Lu MC; Yu CL
    J Formos Med Assoc; 2006 Oct; 105(10):796-803. PubMed ID: 17000452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of formula ophiopogoins in the treatment of xerostomia and pharyngoxerosis.
    Sugano S; Takeyama I; Ogino S; Kenmochi M; Kaneko T
    Acta Otolaryngol Suppl; 1996; 522():124-9. PubMed ID: 8740826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined interventional sialendoscopy and intraductal steroid therapy for recurrent sialadenitis in Sjögren's syndrome: Results of a pilot monocentric trial.
    Capaccio P; Canzi P; Torretta S; Rossi V; Benazzo M; Bossi A; Vitali C; Cavagna L; Pignataro L
    Clin Otolaryngol; 2018 Feb; 43(1):96-102. PubMed ID: 28585263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of oral pilocarpin therapy in the treatment of xerostomia and xerophthalmia in patients with primary Sjögren's syndrome].
    Solans R; Bosch JA; Selva A; Simeón CP; Fonollosa V; Vilardell M
    Med Clin (Barc); 2004 Feb; 122(7):253-5. PubMed ID: 15012873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.